Eisler Capital (UK)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$130M Buy
800,243
+87,648
+12% +$14M 0.6% 39
2024
Q2
$104M Buy
712,595
+156,835
+28% +$23.3M 0.67% 34
2024
Q1
$87.9M Buy
555,760
+285,169
+105% +$45.4M 0.74% 28
2023
Q4
$42.4M Buy
270,591
+135,723
+101% +$20.8M 0.33% 75
2023
Q3
$21M Buy
134,868
+127,868
+1,827% +$21.1M 0.13% 148
2023
Q2
$1.16M Buy
+7,000
New +$1.13M 0.01% 295
2022
Q2
Sell
-139,000
Closed -$24.6M 466
2022
Q1
$24.6M Buy
+139,000
New +$23.7M 0.41% 68
2021
Q4
Sell
-58,600
Closed -$9.46M 386
2021
Q3
$9.46M Buy
+58,600
New +$10M 0.37% 81

Other funds holding JNJ

Eisler Capital (UK)'s JNJ Position: Q3 2024 in Review

Eisler Capital (UK) reduced its Johnson & Johnson (JNJ) stake by 73% in Q3 2024, selling an estimated $5.52M and leaving 13,063 shares worth $2.12M. The position accounts for 0.01% of the portfolio, ranked #437.

Eisler Capital (UK) first reported a position in JNJ in Q3 2021 and has held it in 4 quarters since. The position peaked at $6.97M in Q2 2024. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Eisler Capital (UK) held 13,063 shares of Johnson & Johnson worth $2.12M as of Q3 2024.
  • Eisler Capital (UK) sold 34,658 Johnson & Johnson shares in Q3 2024, an estimated $5.52M.
  • Johnson & Johnson made up 0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #437 holding.
  • Eisler Capital (UK) first reported a position in Johnson & Johnson in Q3 2021 and has held it in 4 quarters since.
  • Eisler Capital (UK)'s Johnson & Johnson position peaked at $6.97M in Q2 2024.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.